Lysosomal acidity may mimic faster mitochondrial removal
After suppression of mechanistic target of rapamycin (mTOR), lysosomal acidity may mimic faster mitochondrial removal, while slower fatal-tumor growth extends life. Independent confirmation of faster removal of whole mitochondria would reject the optical explanation.
Stage of verification
- Hypothesis published2026-09-30
- Indirect evidenceAssessed at 4 of 10
- Direct testAwaited
Map of the hypothesis
Hover over an icon or tap it to see its name.
Where in the body
Biological function
The biological function description is being prepared
Kind of knowledge gap
A double ring marks the main placement where a group contains several values.
Target map
Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.

Indicator or biomarker
mt-Keima signal
A mitochondrial reporter signal that changes with lysosomal acidity and the amount of accumulated reporter
Where this hypothesis actsAfter mTOR suppression, with mitochondrial reporter already accumulated in lysosomes
Hypotheses on this target 1
Telling states apart1
Direct measurement
Indicator replacement

What is proposed
Telling states apart
Calibrate the signal to distinguish acidity effects from mitochondrial clearance
With whatInstrument or assay
HowMeasure acidity and accumulated reporter independently, then compare with independent tracking of labelled mitochondrial delivery and destruction
Possible result
Expected disappearance of the apparent increase in mitophagy after calibration
From the recordИзменение сигнала mt-Keima объясняется независимо измеренной кислотностью и количеством ранее накопленного репортёра.

Enzyme
mTOR
A protein whose suppression reduces excessive transcription of ribosomal genes in the proposed pathway
Where this hypothesis actsIn the presence of a lethal tumour, including during actual mitophagy blockade
Hypotheses on this target 4
Inhibition4
Activation
Lower level
Higher level
Replacement
Protection from degradation
Cofactor removal
Synthesis suppression
Function preservation

What is proposed
Inhibition
Suppress mTOR
With whatNot stated in the record
HowNot stated in the record
Possible result
Possible lifespan extension through delayed lethal tumour growth without broad functional improvement
From the recordПри этом подавление mTOR замедляет рост опухоли даже после устранения дополнительных механизмов остальных гипотез.

Rhythm or programme
Mitophagy
The delivery of mitochondria to lysosomes and removal of whole mitochondria
Where this hypothesis actsDuring mTOR suppression, when testing whether mitophagy mediates lifespan extension
Hypotheses on this target 3
Inhibition1
Activation2
Function preservation
Feedback restoration
Rhythm restoration
Direct measurement

What is proposed
Inhibition
Block mitophagy to test whether the lifespan benefit persists
With whatControlled genetic model
HowSwitch off a selected, unnamed gene and independently track labelled mitochondrial delivery and destruction to verify blockade beyond reporter acidity effects
Possible result
Expected persistence of lifespan extension despite verified mitophagy blockade
From the recordОн сохраняется при действительной блокаде митофагии и повышает SPV_12
All targets of the lab
Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.
Solid and named: the targets of this hypothesis
Explore in depth
The logic
The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.
A longer life after treatment could reflect a later death from one tumor without broader protection against aging. The unexpected move is to propose that an apparent increase in cellular cleanup partly comes from a change in the measuring signal itself. This is a hypothesis generated by the pipeline, not a measured explanation of the survival benefit.
- Suppressing mTOR is proposed to change acidity inside the cell’s disposal compartments.
- Changed acidity alters the signal from mitochondrial material already delivered there, rather than increasing the rate of whole-mitochondrion removal.
- Disabling the selected gene is proposed to alter acidity further, making a signal change resemble successful blocking of mitochondrial removal.
- Separately, suppressing mTOR is proposed to slow the growth of a lethal tumor directly.
- Slower tumor growth postpones death even when mitochondrial removal is genuinely blocked, while long-term functions unrelated to tumors remain unchanged.
A warehouse changes its lighting, making the same pile of discarded equipment look larger in photographs. The photographs could then suggest that more equipment is arriving even when the delivery rate has not changed.
Where the picture breaks: The biological signal depends on acidity and the fate of the marker inside cells. The picture does not establish that acidity actually changes under the proposed treatment, and it does not explain the separate claim about tumor growth.
- Master questionstep 01 of 04
Aging processes may reinforce one another, so acting on a shared cause could benefit several bodily systems at once.
Rests on: The goal assumes that mutually reinforcing aging processes offer a possible shared point of intervention.
AssumptionThe supplied goal takes the existence of a useful shared causal target as a possibility to explore; it supplies no evidence that such a target has been identified.
- Goal pillarstep 02 of 04
The intended output is a collection of life-extension ideas that act through distinct causes.
Rests on: The master question explicitly requests ideas for interventions against shared causes of aging.
Stated in the chain - Gap questionstep 03 of 04
Life extension after suppressing mTOR might survive the blocking of mitophagy, the delivery and breakdown of mitochondria through the cell’s disposal system, because treatment delays only one cause of death while damage continues to reinforce itself across bodily systems.
Rests on: The search for interventions with benefits across systems motivates separating broad protection from postponement of one fatal disease.
LeapThe preceding stages do not supply the move to mTOR, a life-extension effect in a specified population, or mitophagy as its proposed necessary intermediate. The screened sources do not establish that survival benefit or its dependence on mitochondrial removal.
- Hypothesisstep 04 of 04
An apparent increase in mitochondrial removal is proposed to arise partly from changing acidity inside lysosomes, cellular compartments that break down delivered material. A mitochondrial reporter, a detectable marker used to follow mitochondrial material, could change its signal after arriving there without any faster removal of whole mitochondria. Disabling the selected gene could also alter acidity, while a separate slowing of tumor growth could account for longer life.S5
Rests on: The gap question supplies the possibility of survival benefits without mitochondrial removal as the necessary intermediate. S5, in Redox Biology in 2025, reports an acidity-sensitive mitochondrial signal and altered lysosomal acidity in heart muscle cells subjected to oxygen deprivation and restoration; it does not establish the proposed measurement artifact under mTOR suppression or the tumor-based explanation of longer life.
Supported by literature
What is carried, and what is not. Of the five proposed links listed here, one has partial direct support from the screened literature: S5, in Redox Biology in 2025, supports acidity sensitivity of the measurement in stressed heart muscle cells, but not a treatment-induced signal change at an unchanged removal rate. The supplied sources do not establish the proposed sequence end to end or its separate tumor-to-survival explanation.S5
Where the reasoning is carried by something unstated · 2
- Master question. The supplied goal takes the existence of a useful shared causal target as a possibility to explore; it supplies no evidence that such a target has been identified.
- Gap question. The preceding stages do not supply the move to mTOR, a life-extension effect in a specified population, or mitophagy as its proposed necessary intermediate. The screened sources do not establish that survival benefit or its dependence on mitochondrial removal. Establish the missing link before relying on this step.
How a result here could mislead · 3
- A change in mt-Keima, an acidity-sensitive fluorescent marker of mitochondrial material, could be mistaken for a change in the rate of mitochondrial removal. Agreement between two acidity-sensitive markers would preserve the same ambiguity. What closes it: Acidity and the amount of previously accumulated marker must be measured independently, and the signal must be calibrated against them. Delivery and subsequent breakdown of labeled mitochondrial material must also be followed with measurements that do not share the same dependence on acidity.
- A signal change after disabling a gene could be treated as proof that mitochondrial removal was blocked, even if the gene changed only the measurement conditions. Faster replacement of individual mitochondrial proteins could also be mistaken for removal of whole mitochondria. What closes it: Successful blocking must be established by tracking delivery and breakdown of whole mitochondria independently of acidity. The selected gene and the criterion for successful blocking are not specified in the supplied material and must be fixed before interpreting survival.
- Longer survival accompanied by slower tumor growth could be credited entirely to direct tumor suppression even if improved breathing, greater resistance to cell injury, fewer new cellular injuries, or better removal of damaged proteins also contributes. What closes it: Tumor growth and causes of death must be assessed alongside long-term functions unrelated to tumors, selected in advance. The hypothesis requires excluding the rival mechanisms, but the supplied material does not specify how their contributions would be removed or verified.
What would make this wrong. Independent evidence that treatment accelerates removal of whole mitochondria would refute the hypothesis’s unchanged-removal claim, even if acidity also affects the reporter. Loss of the survival benefit after a verified, specific block of mitochondrial removal would contradict its claimed independence from that process. Reproducible long-term improvement in the preselected functions unrelated to tumors would contradict the predicted absence of broader functional benefit.
What it would change. If this account held, the observed survival benefit would not establish that treatment interrupts a shared cause of aging across bodily systems. Work seeking such a shared intervention would need to distinguish delayed tumor death from broader functional protection and verify mitochondrial removal independently of the acidity-sensitive signal. Even then, this explanation would not establish effects in humans or across other tissues and causes of death; the supplied rivals mention old mice, but the endpoint does not specify its population, duration, or the meanings of its two named outcome measures.
Sources read · 7
PRKN-regulated mitophagy and cellular senescence during COPD pathogenesis. · Autophagy · 2019
“Mitophagy plays a crucial role in eliminating damaged mitochondria, and is governed by the PINK1 (PTEN induced putative protein kinase 1)-PRKN (parkin RBR E3 ubiquitin protein ligase) pathway.”
Does not settle: Источник оставляет открытыми влияние подавления mTOR на кислотность лизосом и сигнал митохондриального репортёра, скорость удаления митохондрий, связь выключения гена с кислотностью, рост опухоли, продолжительность жизни и показатели SPV_11 и SPV_12.
AMPK maintains the activation of hepatic stellate cells through mitophagy-induced metabolic reprogramming. · Journal of molecular cell biology · 2026
“AMPKα deficiency in HSCs prevents the metabolic switch necessary for the induction of oxidative phosphorylation via mitophagy.”
Does not settle: This source does not establish effects of mTOR inhibition, lysosomal acidity or reporter artifacts, mitochondrial-removal rates, tumor growth, lifespan, SPV_11 or SPV_12, or whether mitophagy blockade preserves any lifespan benefit.
MG132-mediated inhibition of rabies virus replication via the Nrf2/SQSTM1/PINK1/Parkin autophagy pathway. · Virology journal · 2026
“Rapamycin-induced autophagy and Parkin-mediated mitophagy could also be inhibited by MG132.”
Does not settle: Источник не оценивает кислотность лизосом, оптические артефакты митохондриального репортёра, скорость удаления митохондрий, генетическую блокаду митофагии, опухолевый рост или показатели SPV_11 и SPV_12.
Peroxiredoxin Ⅲ mitigates mitochondrial H2O2-mediated damage and supports quality control in cardiomyocytes under hypoxia-reoxygenation stress. · Redox biology · 2025
“The pH-sensitive fluorescence shift of mt-Keima from green (neutral pH) to red (acidic lysosomal pH) enables reliable tracking of mitochondrial degradation.”
Does not settle: Источник показывает pH-зависимость сигнала mt-Keima и изменение кислотности лизосом при дефиците PrxIII в кардиомиоцитах при гипоксии-реоксигенации. Он не изучает подавление mTOR, опухоли, продолжительность жизни, SPV_11 или SPV_12, а также не устанавливает, что изменение сигнала происходит при неизменной скорости удаления митохондрий или сохраняется при блокаде митофагии.
Everolimus alleviates cognitive dysfunction in 5×FAD mice by regulating mitochondrial function and oxidative stress. · European journal of pharmacology · 2025
“Although these findings suggest an mTOR-dependent mechanism involving mitochondrial protection, the study did not investigate autophagy or mitophagy pathways, a limitation that should be addressed in future research.”
Does not settle: Источник не устанавливает влияние подавления mTOR на митофагию, кислотность лизосом, оптические артефакты репортёров, роль выбранного гена, удаление митохондрий, опухоль, продолжительность жизни или показатели SPV_11 и SPV_12.
Acid triggering highly-efficient release of reactive oxygen species to block mitochondrial-mediated homeostasis maintenance for accelerating cell death. · Analytica chimica acta · 2025
“the damaged mitochondria activate the mitophagy process, which further boosts the ROS generation of the TTBI owing to the acidic environment in the lysosome”
Does not settle: Источник не исследует подавление mTOR, оптические репортёры, скорость удаления митохондрий, выключение гена, продолжительность жизни, опухолевый рост, SPV_11 или SPV_12.
Cannabidiol inhibits human glioma by induction of lethal mitophagy through activating TRPV4. · Autophagy · 2021
“Transcriptome analysis and other results demonstrated that ER stress and the ATF4-DDIT3-TRIB3-AKT-MTOR axis downstream of TRPV4 were involved in CBD-induced mitophagy in glioma cells.”
Does not settle: This source does not establish lysosomal-acidity optical effects, unchanged mitochondrial-removal rates, gene-dependent acidity artifacts, mitophagy blockade, lifespan effects, or SPV_11/SPV_12 outcomes.
The gap this hypothesis explains
Two live hypotheses pull in opposite directions here, and the field has not chosen between them.
Does blocking a growth-control protein still extend mouse life when damaged cell powerhouses cannot be cleared?
Original wording · exactly as the pipeline generated it
Сохранится ли продление жизни при подавлении mTOR после выключения предполагаемого посредника, митофагии, если межсистемное усиление повреждений останется прежним, а весь выигрыш объяснит отсрочка одной причины смерти?
What this question is asking
The question asks whether removing damaged energy-producing structures inside cells is necessary for a treatment to extend mouse life. It concerns suppression of mammalian target of rapamycin (mTOR), a protein involved in controlling cell growth, after disabling mitophagy, the process that removes those structures. The relevant comparison is whether suppression still increases remaining lifespan relative to no suppression when this removal process is disabled, compared with when it remains available. The question also considers a conditional explanation: damage in different body systems might continue to worsen other systems' damage, while the entire survival benefit comes from postponing just one cause of death.
- Mammalian target of rapamycin (mTOR)
- A protein involved in controlling cell growth. Suppression means reducing its activity; the question asks whether the resulting lifespan effect requires removal of damaged cellular powerhouses.
- Mitochondria
- Structures inside cells involved in producing usable energy, described here as cellular powerhouses. Their removal is the proposed link between treatment and longer life.
- Mitophagy
- The cellular process that removes mitochondria, including damaged ones. The question treats it as a possible necessary step in the lifespan effect, which the supplied sources do not establish.
- Autophagy
- The broader cellular process for removing and recycling material within cells. Mitophagy is the mitochondria-focused form; a finding about the broader process does not automatically establish the particular role of mitophagy.
- Mediator and mediation
- A mediator is an intermediate process through which an intervention causes an outcome. Here, mediation would mean that suppression of mTOR extends life through its effect on mitophagy, rather than the two simply being associated.
- Intersystem damage amplification
- The proposed process in which damage in one body system worsens damage in another. Its persistence during treatment is a condition considered by the question, not a finding established by the supplied sources.
- Rapamycin
- The treatment evaluated in the mouse lifespan findings quoted in S2. Those findings describe survival responses but do not establish the proposed role of mitophagy.
- Corylin
- The compound studied in S3. The supplied quotation reports a lifespan benefit in female mice without a comparable benefit in males.
- Median lifespan
- The time by which half of a studied group has died. It summarizes survival and does not identify which causes of death changed.
- Survival rate at a stated age
- The proportion of a group still alive at that age. S3 reports a comparison at 125 weeks; the supplied quotation does not give the underlying proportions.
- Mouse strain
- A mouse breeding line with a particular inherited background. S2 reports that strain influences the size of the lifespan response.
- Kisspeptin-10
- The molecule used in S5 to stimulate cellular removal processes. The supplied quotation describes a route independent of mTOR, so it does not establish mediation of a treatment that suppresses mTOR.
- Cellular signaling
- Processes through which activity in one part of a cell changes activity elsewhere in it. A signaling connection alone does not establish an effect on whole-animal lifespan.
- Human neuronal cell line
- Human cells maintained in laboratory culture and used to study nerve-cell processes. Findings in these cells do not by themselves establish survival effects in an animal.
- Hippocampus and cultured hippocampal tissue
- The hippocampus is a brain region. Cultured hippocampal tissue is tissue from that region maintained outside the animal; S5 includes this preparation alongside cell cultures and aging rats.
mTOR suppression is associated with longer mouse survival, mitophagy is its proposed cellular mediator, and the survival gain might occur with unchanged intersystem damage amplification because only one cause of death is delayed.
The proposed explanation places removal of damaged cellular powerhouses between blocking a growth-control protein and longer life. It contrasts protection across several body systems with a scenario in which damage still spreads between systems but one fatal condition occurs later. Establishing these links would distinguish a shared protective process from a narrower explanation of longer survival.
S2 reports generally favorable mouse lifespan findings for rapamycin, and S3 reports longer life in female mice receiving corylin. Neither supplied quotation establishes that removal of damaged cellular structures mediates those benefits. S5 instead reports stimulation of that removal through a route independent of mTOR; it does not establish the proposed mediation. None of the supplied sources establishes unchanged damage amplification between systems or a survival gain fully explained by delaying one cause of death. Those last conditions are hypothetical in the question, and this background-focused selection is too limited to establish or refute the complete premise.S2S3S5
The same question asked without the part nothing read establishes:
- Does suppressing the growth-control protein extend mouse life when removal of damaged cellular powerhouses is disabled?
- Does longer mouse life under suppression of the growth-control protein reflect lasting benefits across several body systems or postponement of one cause of death?
- The lifespan benefit persists Under the question's assumption that removal of damaged cellular powerhouses has been disabled, a persisting benefit would mean that this removal is not necessary for the entire survival effect. If postponement of one cause of death accounts for all of that benefit, longer life would not by itself demonstrate protection across several body systems.
- The lifespan benefit disappears Losing the benefit would be consistent with the removal process being necessary for the survival effect in the stated conditions. That result alone would still not establish that the process protects several systems or interrupts damage spreading between them.
- The lifespan benefit becomes smaller A smaller benefit would be consistent with the removal process contributing to, but not fully accounting for, longer survival. The remaining benefit would still need to be distinguished from the question's alternative explanation of postponing one cause of death.
The proposed explanation links suppression of the growth-control protein to removal of damaged cellular structures, then to lasting benefits across several body systems, and finally to longer life. Each connection matters because longer survival alone does not establish the preceding steps. Under the question's alternative explanation, postponing one fatal disease could extend life while damage elsewhere continues. Mistaking that outcome for protection across several systems would overstate what the survival findings establish.
Подавление mTOR уровня RL-2 связано с мышиной выживаемостью; митофагическое посредничество уровня RL-1 показано на клетках.
Выигрыш оставшейся жизни должен сопровождаться устойчивой пользой нескольким системам и проверенным общим посредничеством за единый горизонт наблюдения.
Не установлено, объясняет ли митофагия многосистемный выигрыш жизни; подавление отдельной смертельной патологии может воспроизводить наблюдаемую выживаемость.
The mechanism it proposes
The engine's own statement of the hypothesis, in full.
Предполагаемое усиление митофагии после подавления mTOR частично представляет собой оптический эффект изменения кислотности лизосом. Уже доставленный туда митохондриальный репортёр меняет сигнал, хотя скорость удаления целых митохондрий остаётся прежней. Выключение выбранного гена может дополнительно менять кислотность и тем самым создавать ложную картину выключения посредника. Реальный выигрыш жизни в этой версии обусловлен прямым торможением роста смертельной опухоли. Он сохраняется при действительной блокаде митофагии и повышает SPV_12, но общего митофагического посредничества и согласованного улучшения SPV_11 не возникает.
Testing and possible results
The prediction that would tell it apart
A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.
Изменение сигнала mt-Keima объясняется независимо измеренной кислотностью и количеством ранее накопленного репортёра. После соответствующей калибровки увеличение потока исчезает; независимое отслеживание доставки и разрушения меченых митохондрий также не выявляет ускорения. При этом подавление mTOR замедляет рост опухоли даже после устранения дополнительных механизмов остальных гипотез. Длительные траектории заранее выбранных неопухолевых функций остаются прежними. Подтверждение ускоренного удаления целых митохондрий независимыми методами опровергает оптическую часть гипотезы.
States a measurable outcome; comparing rivals needs more conditions. The prediction states measurable qualitative outcomes and an explicit rejection condition for its optical component. No rival prediction is supplied. Only a bench experiment would settle it.
What testing it would take
The engine's own read on whether this is testable with methods that already exist.
Можно сочетать калибровку кислотности, наблюдение доставки митохондрий и отслеживание судьбы заранее меченого материала. Два репортёра, оба зависящие от кислотности, не дают независимой проверки. Обновление отдельных митохондриальных белков также нельзя автоматически приравнивать к удалению целой органеллы.
Other explanations
Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.
Изменение сигнала mt-Keima объясняется независимо измеренной кислотностью и количеством ранее накопленного репортёра. После соответствующей калибровки увеличение потока исчезает; независимое отслеживание доставки и разрушения меченых митохондрий также не выявляет ускорения. При этом подавление mTOR замедляет рост опухоли даже после устранения дополнительных механизмов остальных гипотез. Длительные траектории заранее выбранных неопухолевых функций остаются прежними. Подтверждение ускоренного удаления целых митохондрий независимыми методами опровергает оптическую часть гипотезы.
- What would separate them
Rapamycin may extend life by changing calcium control of breathing-muscle contraction predicts: При подтверждённой блокаде митофагии рапамицин сохраняет выигрыш оставшейся жизни и повышает устойчивость диафрагмы к повторным сокращениям. Сопоставимое подавление mTOR генетическим способом этого результата не воспроизводит. Лиганд FKBP12, сохраняющий необходимое кальциевое действие и не подавляющий mTOR, воспроизводит оба эффекта. Избирательное устранение кальциевого действия рапамицина отменяет выигрыш при сохранённом подавлении mTOR. Сохранение пользы генетического подавления mTOR после такого устранения опровергает гипотезу.
- What would separate them
Growth-signal inhibition may release a brake on protein kinase B and limit cell death predicts: После блокады митофагии сохраняются краткий ответ AKT, уменьшение апоптоза после повторной нагрузки и замедление функционального ухудшения нескольких систем. Избирательное устранение вызванного лечением ответа AKT отменяет эти эффекты при сопоставимом подавлении mTOR. Модель, построенная по ответам на одиночные слабые нагрузки, заранее предсказывает меньший пик повреждения при их сочетании. Если защита сохраняется при устранённом ответе AKT либо измеренный ответ усиливает повреждение, гипотеза отвергается.
- What would separate them
Reducing ribosomal gene transcription may protect tissues by limiting genome damage predicts: При подавленной митофагии лечение уменьшает гибриды РНК и ДНК и новые разрывы в рибосомных генах до появления функциональной пользы. Направленное удаление патологических гибридов рибонуклеазой H1 воспроизводит защиту и уменьшает дополнительный эффект рапамицина в диапазоне, свободном от потолочного эффекта. Избирательное восстановление исходного уровня гибридов при сохранённом подавлении mTOR отменяет защиту. Если лечение сохраняет функциональную и жизненную пользу при экспериментально восстановленном геномном повреждении, эта версия отвергается.
- Rival 04 of 04What would separate them
Ubiquitin-dependent protein disposal may preserve tissue function despite defective mitophagy predicts: После выключения митофагии сохраняются ускоренное разрушение заранее меченых повреждённых цитозольных белков и функциональная польза. Устранение именно вызванного лечением прироста убиквитин-зависимого разрушения отменяет пользу, хотя подавление mTOR и изменения транскрипции рибосомных генов сохраняются. Независимое восстановление протеасомного потока возвращает защиту. Сохранение пользы при отсутствии дополнительного разрушения соответствующих белков опровергает гипотезу.
What stands behind it
Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.
This hypothesis states no figure and cites no study, so there is nothing here to trace.
What it would take to refute it. Nothing already retrieved carries the prediction’s terms and it names no measurement this layer can route to a public dataset, so the bench is the residual — not a finding against it.
0 citation handles extracted; 1 Europe PMC search run; 0 records examined; 0 sources stored for enrichment, 0 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.